Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Trang Pham

Showing results (121-130 of 124) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 124 results.
Vaccine|January 12, 2012
Inclusion of a CRF01_AE HIV envelope protein boost with a DNA/MVA prime-boost vaccine: Impact on humoral and cellular immunogenicity and viral load reduction after SHIV-E challengeJosephine H Cox, Maria G Ferrari, Patricia Earl, et al.
Science Signaling|September 13, 2018
The Hippo pathway effector TAZ induces TEAD-dependent liver inflammation and tumorsThijs J Hagenbeek, Joshua D Webster, Noelyn M Kljavin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2025
PI3Kα Inhibitor and Degrader Inavolisib Can Co-opt FGFR2 to Enhance Responses in Patients with PIK3CA-Mutated Solid Tumors and in Preclinical ModelsDejan Juric, Kyung Song, Radia M Johnson, et al.
The Lancet Regional Health. Southeast Asia|July 1, 2022
The global response: How cities and provinces around the globe tackled Covid-19 outbreaks in 2021Nityanand Jain, I-Chun Hung, Hitomi Kimura, et al.
Pageof 13

Showing results (121-130 of 124) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 124 results.
Vaccine|January 12, 2012
Inclusion of a CRF01_AE HIV envelope protein boost with a DNA/MVA prime-boost vaccine: Impact on humoral and cellular immunogenicity and viral load reduction after SHIV-E challengeJosephine H Cox, Maria G Ferrari, Patricia Earl, et al.
Science Signaling|September 13, 2018
The Hippo pathway effector TAZ induces TEAD-dependent liver inflammation and tumorsThijs J Hagenbeek, Joshua D Webster, Noelyn M Kljavin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2025
PI3Kα Inhibitor and Degrader Inavolisib Can Co-opt FGFR2 to Enhance Responses in Patients with PIK3CA-Mutated Solid Tumors and in Preclinical ModelsDejan Juric, Kyung Song, Radia M Johnson, et al.
The Lancet Regional Health. Southeast Asia|July 1, 2022
The global response: How cities and provinces around the globe tackled Covid-19 outbreaks in 2021Nityanand Jain, I-Chun Hung, Hitomi Kimura, et al.
Pageof 13